NUCLEASE PROBE TECHNOLOGIES Trademark

Trademark Overview


On Tuesday, December 21, 2021, a trademark application was filed for NUCLEASE PROBE TECHNOLOGIES with the United States Patent and Trademark Office. The USPTO has given the NUCLEASE PROBE TECHNOLOGIES trademark a serial number of 97182177. The federal status of this trademark filing is REGISTERED as of Tuesday, January 16, 2024. This trademark is owned by Nuclease Probe Technologies, Inc.. The NUCLEASE PROBE TECHNOLOGIES trademark is filed in the Pharmaceutical Products category with the following description:

Medical diagnostic test kits for sample analysis, namely, medical diagnostic kits comprised of reagents and assays that include molecular probes or microbiological culture media that includes molecular probes for analysis of biological samples for medical and veterinary purposes; medical diagnostic test kits comprised of reagents and assays that include molecular probes or microbiological culture media that includes molecular probes for sample analysis of bodily fluids, blood, skin cells, and tissues in humans and animals for use in disease detection, namely, bacterial infections, fungal infections, antibiotic-resistant bacterial infections, bloodstream pathogens, cancers and skin conditions; medical diagnostic test kits comprised of reagents and assays for testing of biological samples, namely, bodily fluids, blood, skin cells, and tissues in humans and animals for use in disease detection, namely, bacterial infections, fungal infections, antibiotic-resistant bacterial infections, blo...
nuclease probe technologies

General Information


Serial Number97182177
Word MarkNUCLEASE PROBE TECHNOLOGIES
Filing DateTuesday, December 21, 2021
Status700 - REGISTERED
Status DateTuesday, January 16, 2024
Registration Number7281241
Registration DateTuesday, January 16, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical diagnostic test kits for sample analysis, namely, medical diagnostic kits comprised of reagents and assays that include molecular probes or microbiological culture media that includes molecular probes for analysis of biological samples for medical and veterinary purposes; medical diagnostic test kits comprised of reagents and assays that include molecular probes or microbiological culture media that includes molecular probes for sample analysis of bodily fluids, blood, skin cells, and tissues in humans and animals for use in disease detection, namely, bacterial infections, fungal infections, antibiotic-resistant bacterial infections, bloodstream pathogens, cancers and skin conditions; medical diagnostic test kits comprised of reagents and assays for testing of biological samples, namely, bodily fluids, blood, skin cells, and tissues in humans and animals for use in disease detection, namely, bacterial infections, fungal infections, antibiotic-resistant bacterial infections, bloodstream pathogens, cancers, and skin infections; diagnostic tools, namely, medical diagnostic reagents and assays for testing of samples for use in disease detection, namely, bacterial infections, fungal infections, antibiotic-resistant bacterial infections, bloodstream pathogens, cancers and skin infections
Disclaimer with Predetermined Text"TECHNOLOGIES"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 27, 2021
Primary Code005
First Use Anywhere DateSunday, July 31, 2022
First Use In Commerce DateSunday, July 31, 2022

Trademark Owner History


Party NameNuclease Probe Technologies, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBelmont, MA 02478

Party NameNuclease Probe Technologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBelmont, MA 02478

Trademark Events


Event DateEvent Description
Tuesday, January 16, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 16, 2024REGISTERED-SUPPLEMENTAL REGISTER
Thursday, July 27, 2023APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Friday, June 23, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 23, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 23, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 25, 2023NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Wednesday, May 24, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 24, 2023NON-FINAL ACTION E-MAILED
Wednesday, May 24, 2023NON-FINAL ACTION WRITTEN
Wednesday, May 24, 2023USE AMENDMENT ACCEPTED
Tuesday, April 11, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 10, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 11, 2023AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, April 11, 2023USE AMENDMENT FILED
Monday, April 10, 2023TEAS AMENDMENT OF USE RECEIVED
Thursday, October 13, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 13, 2022NON-FINAL ACTION E-MAILED
Thursday, October 13, 2022NON-FINAL ACTION WRITTEN
Monday, September 26, 2022ASSIGNED TO EXAMINER
Thursday, June 16, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 16, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 16, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 27, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 24, 2021NEW APPLICATION ENTERED